HealthTech Hub Masterclass: Discovering your Innovation's Commercialisation Potential

Are you a clinical researcher or academic with a great idea? 
Hear from the experts on how to know if your idea has commercial potential.

Join us to learn how to effectively communicate your ideas, explore the commercial potential, attract the right investors, and reach your target audience.
Discover strategies to bridge the gap between your medical expertise and the business world of health tech.

Don't let your potentially life-changing innovations remain hidden. Learn how to shine a spotlight on your work and make a larger impact in healthcare.

What You Will Learn:

• Intellectual property for research innovation
• Pathways to commercialise
• Discovering commercialisation potential - Med Device, therapeutics, diagnostics
• Clinical translation & commercial vehicle, key things to consider
• Industry insights from idea to market
  
  

Agenda:

9:30am - 10am : Registration and morning tea
10am - 11:30am : Masterclass
11:30am - 12pm : Panel discussion / Q&A

Meet the Experts:

Dr Melissa Mail 
Head of Commercialisation / Children's Medical Research Institute  

Dr Melissa Mail is passionate about delivering leading technology innovations to the market and achieving successful commercial outcomes. Throughout her career, Melissa has worked at the interface between industry and academia and brings a broad strategic perspective with a focus on technology performance and aligning intellectual property assets with commercial strategy.

Melissa’s strengths lie in establishing strong relationships with industry, research and government partners. She has a PhD in Genetics, a Bachelor of Laws (Honours) and a Master of Intellectual Property Law. Melissa is also a Fellow of the Institute of Patent and Trade Mark Attorneys and a graduate of the Australian Institute of Company Directors

Jess Smith 
Investment Manager/  Brandon Capital

Before joining Brandon, Jess was a Senior Associate patent attorney with FB Rice in Sydney and Melbourne. In her earlier, scientific research career, Jess worked on projects focused on the development of small molecule drugs for treating cancer, viral diseases and blood disorders and held post-doctoral positions in industry (Avexa Limited), academia (Monash University) and at the CSIRO.

Jess is currently a director of Sicario and Vaxxas.

Gordon Malouf
Cicada Innovations

With over two decades of experience in the medical device industry, Gordon has held key roles in Applied Research, Product Development, Technical Due Diligence, Product Marketing, Program Management, and Medical Affairs. His most recent venture was as a co-founder of an in-house medical device startup. In five years, the startup expanded to a team of 50 employees across five countries with hundreds of units sold into the United States, securing reimbursement from both the Federal Government and major private insurers.

Gordon is passionate about innovation and the collaboration between Product Development, Marketing and Evidence Generation. His extensive international experience, having lived and worked in Sydney, Stockholm, Singapore, and Tokyo, has equipped him with a distinctive perspective on teams, culture and communication.

Philip Crealy
Founder, Director @ Equinox Medical | Early Stage Ventures

Over 15 years’ experience leading pharmaceutical companies and medical affairs, Philip has worked across the Pharma industry as medical and scientific affairs manager before embarking on his own start-up journey as a founder in several innovations since 2017. Currently director of Centralyze, focusing on early-stage investments, commercialisation and global partnerships for Australian life science technologies, and director of Equinox Medical, focusing on delivering best-in-market medical supplies. 

Philip has led over 25 successful major medical product launches. and is also the found of Petri Exchange, an incubator of early stage biotech companies in Australia.

-----------

Don't miss this opportunity to gain valuable insights from industry experts and network with fellow health tech innovators.

Morning tea will be provided

Register now to secure your spot in this must-attend masterclass for health tech entrepreneurs looking to amplify their presence in the market!

Cicada Innovations is proud to be collaborating with the Westmead Health & Innovation District, Australia’s fastest-growing health and innovation precinct, for this commercialisation masterclass series. These masterclasses are to help bridge the gap between research and commercialisation.

Find out more about the Cicada HealthTech Hub 

The Cicada HealthTech Hub is proudly supported by NSW Government and is part of the Westmead’s Health & Innovation District. The district includes 4 major hospitals, 4 world-leading medical research institutes, 2 university campuses and the largest research-intensive pathology service in NSW. By 2036, the number of full-time staff will increase to more than 50,000 and the number of students will expand to more than 10,000. Among the first projects for development is a viral vector advanced manufacturing facility to provide ground-breaking trial therapies for infections, cancer and genetic diseases.